Stehman-Breen Catherine
Tenaya Therapeutics, Inc. · Director
Stehman-Breen Catherine is listed in filings as Director at Tenaya Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including 12 public disclosures. Recent filings connect the profile to Tenaya Therapeutics, Inc. (TNYA), Generation Bio Co. (GBIO), and Dyne Therapeutics, Inc. (DYN). The current snapshot covers public activity from Oct 21, 2024 to May 29, 2026. Reported amounts are shown as $95.9K to $398.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||